Posts by: Kara Elam

Kara Elam

Kara Elam is currently working on her Doctorate in Health Policy. She holds Master Degrees in both epidemiology and microbiology. Her research interests include emerging viral diseases, the intersection of human rights and intellectual property rights, and ending violence against women.

May 8, 2017May 8, 2017

Recent Merger to Focus on Carbon Monoxide Therapies for Chronic Lung Diseases, Other Conditions

Idiopathic Pulmonary Fibrosis, News

The recently announced merger of Proterris, a clinical development stage company focused on therapeutic applications of low-dose carbon monoxide (CO), and Alfama, a global leader in the development of Carbon ... Read more

March 7, 2017March 7, 2017

Treatment Seen to Lessen Fibrotic Scarring That Causes Lung Transplants to Fail

Bronchiolitis, COPD, Cystic Fibrosis, Idiopathic Pulmonary Fibrosis, News

Treatment may be able prevent the progressive accumulation of scar tissue (fibrosis) in newly transplanted lungs that eventually cause those organs to fail, researchers at the University of Michigan report. The study, “Autocrine lysophosphatidic ... Read more

June 3, 2016June 6, 2016

Researchers Propose Repurposing Tromethamine as Potential CF Treatment

Cystic Fibrosis

This week, a team of interdisciplinary researchers led by Dr. Joseph Zabner, MD, of the University of Iowa’s Carver College of Medicine, published a study that provides evidence for the ... Read more

April 18, 2016April 19, 2016

FDA Approves Corbus Phase 2 Trial Extension of Systemic Sclerosis Drug Resunab

News, Scleroderma

Corbus Pharmaceuticals, a clinical stage company targeting rare, chronic inflammatory and fibrotic diseases, recently received approval by the U.S. Food and Drug Administration (FDA) for a 12-month open-label extension trial ... Read more

February 23, 2016February 24, 2016

Researchers Shed Light on Idiopathic Pulmonary Fibrosis’ Impact on Patients, Caregivers

Idiopathic Pulmonary Fibrosis, News

An article published in The European Respiratory Journal used a qualitative study design to increase awareness of what it means to live with idiopathic pulmonary fibrosis (IPF), both from the patients’ ... Read more

January 19, 2016

Study’s Focus on Fall Asthma Outbreaks Looks Promising for Children, Teens

Asthma, News

A newly released study has important clinical implications for the prevention and reduction of autumn asthma exacerbations in children. The study, “Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost ... Read more

November 9, 2015November 9, 2015

Microorganism in CF, Other Bacterial Infections May Have Met Its Match

Cystic Fibrosis, News

Researchers from the University of Florida Health (UF Health) system have developed new medicinal compounds that may have important implications for cystic fibrosis patients who suffer from biofilm-associated bacterial infections. Biofilms ... Read more

September 28, 2015November 5, 2015

Bellerophon Makes Two Important Announcements For Pulmonary Arterial Hypertension Therapy Program INOpulse

News, Pulmonary Hypertension

Last week, Bellerophon Therapeutics, Inc., (Nasdaq:BLPH), a clinical-stage biotherapeutics company focused on developing therapies that address significant unmet medical needs in the treatment of cardiopulmonary and cardiac diseases, made two ... Read more

August 27, 2015November 5, 2015

Researchers Recommend Against Pseudomonas Aeruginosa Vaccines in CF Patients

Cystic Fibrosis, News

Recently, a team of researchers from the Nordic Cochrane Centre (NCC) an independent research center that is part of The Cochrane Collaboration, an international network of individuals and institutions committed ... Read more

August 14, 2015November 5, 2015

Study Identifies New Drug Target for Pulmonary Arterial Hypertension

News, Pulmonary Hypertension

Recently, a group of researchers from the Imperial College of London released study results in which they identified a gene that could lead to future efficacious treatment options for patients ... Read more